Showing posts with label Adasuve. Show all posts
Showing posts with label Adasuve. Show all posts
Friday, April 12, 2013
Sunday, December 30, 2012
FDA Approves Adasuve (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults
We know that, Loxapine (Loxapac, Loxitane) is a typical antipsychotic medication, used primarily in the treatment of schizophrenia. It is a member of the dibenzoxazepine class and structurally related to clozapine (which belongs to the chemically akin class of dibenzodiazepines). Several researchers have argued that Loxapine may behave as an atypical antipsychotic. Loxapine may be metabolized by N-demethylation to amoxapine, a tetracyclic antidepressant. ........
Labels:
Adasuve,
antipsychotic,
Drug Discovery,
Loxapine (Loxapac,
Loxitane)
Subscribe to:
Posts (Atom)